Epidemiology of Roller Hockey Related Injuries.

October 14, 2021 updated by: Hugo Olmedillas Fernandez, University of Oviedo
Roller Hockey is a sport played on a 40*20 metres rink characterized by combined periods of high intensity and short breaks, there´s a lack of epidemiological studies in this field. In line with the well-established model of sports injury prevention research proffered by van Mechelen, the first stage in this process is establishing the extent of the problem i.e. injury incidence, severity and burden. Through an online survey filled by semiprofessional athletes, it is posible to obtain all this important information. This way, it will be possible to fulfill a gap in the literature and take action in the near future in order to reduce the prevalence of injuries in this sport.

Study Overview

Status

Completed

Conditions

Detailed Description

A retrospective study was performed in male Roller Hockey players. 275 players will be recruited. Data of all injury along a whole season will be collected. Patients' information, including age, number of years playing, skill level and injured body part, will be analysed.

Study Type

Observational

Enrollment (Actual)

106

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Asturias
      • Oviedo, Asturias, Spain, 33006
        • Hugo Olmedillas

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Roller Hockey players playing in the spanish senior´s third division league

Description

Inclusion Criteria: Being a roller hockey player, play for one of the teams who participated in the 2020-2021 season third division league (Ok Liga Bronce). Play in at least one match in the season.

-

Exclusion Criteria: Being unable to understand the questionaire, do not accept on participating in the study.

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
No intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Injury prevalence
Time Frame: September 2020-June 2021
Injury prevalence rates [Injury prevalence rates calculated per 1000 hours of play]
September 2020-June 2021

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Injury burden
Time Frame: September 2020-June 2021
Days lost per 1000 hours of exposure
September 2020-June 2021
Injury prevalence according to occurrence
Time Frame: September 2020-June 2021
Number of injuries sustained during training/ Number of injuries sustained during a match (% of all)
September 2020-June 2021
Injury prevalence by mechanism of injury
Time Frame: September 2020-June 2021
Number of injuries according to the mechanism of injury (Contact (Direct or indirect) or Non-Contact) (% of all)
September 2020-June 2021
Injury prevalence according to location
Time Frame: September 2020-June 2021
Distribution of injuries according to location of the injury (on the body, % of all)
September 2020-June 2021
Injury prevalence according to tissue affected
Time Frame: September 2020-June 2021
Description of the distribution of injuries according to the type of the injury (muscle only) (% of all)
September 2020-June 2021

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2021

Primary Completion (Actual)

September 1, 2021

Study Completion (Actual)

September 25, 2021

Study Registration Dates

First Submitted

August 9, 2021

First Submitted That Met QC Criteria

August 9, 2021

First Posted (Actual)

August 16, 2021

Study Record Updates

Last Update Posted (Actual)

October 15, 2021

Last Update Submitted That Met QC Criteria

October 14, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UO2021-02

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sports Injury

3
Subscribe